Diabetes Tracker - myGlucose is a manual blood sugar logging tool for individuals managing diabetes or prediabetes, available on iOS.
The App DNA
What makes this app unique?
The app removes the cognitive friction of complex interfaces for users who prefer a simple, manual record of their daily glucose readings over automated, high-maintenance alternatives.
For Individuals managing type 1 diabetes, type 2 diabetes, or prediabetes who require a manual logging tool for glucose monitoring.
What does it look like?
Key features
Manual entry of blood glucose levels including fasting and post-meal readings.
Charts and graphs displaying blood sugar changes over weeks and months.
Centralized repository for all historical glucose readings.
How much does it cost?
The app is currently free with no visible subscription gates or monetization mechanics.
Velocity
Dormant developmentShow more...
Diabetes Tracker - myGlucose has not received a feature update or maintenance patch in 176 days. The development momentum is currently stalled, with no activity recorded since the initial release. Given the lack of updates over the last six months, the app is classified as a zombie project.
Who built it?
Pratik Kadam
9 apps tracked · Medical
TV Remote Control - Android TV
iFonts: Fonts Keyboard & Emoji
Forex Calculator : Pips & Lot
Compress videos - Size Reduce
Lock Apps :Photos & App Locker
Forex Calculator & Tools
Forex Market Hours & Sessions
Scanner Pro: OCR & PDF ScannerUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Diabetes Tracker - myGlucose
How's the Medical market?
Diabetes Tracker - myGlucose maintains a low-profile presence with only 4 ratings on the iOS platform. The lack of updates since March 2026 signals a maintenance-only posture that prevents it from competing with active, feature-rich medical trackers.
The rivals identified
The Analyst's Read
Key takeaways for Diabetes Tracker - myGlucose
Where is it heading?
The glucose-tracking category is rapidly consolidating around automated data synchronization and CGM integration. Diabetes Tracker - myGlucose is currently exposed due to its manual-only design and lack of development activity, which will likely lead to further loss of relevance as users migrate to more integrated solutions.
- The 6-month development silence since the March 2026 launch indicates a zombie-state product, which erodes user trust in long-term data reliability.
The SWOT
- Minimalist interface reduces logging friction for manual-entry users
- Apple Health integration would provide a necessary data-sync differentiator
Next best moves
Audit Apple Health integration feasibility because manual-only entry is a category-wide churn risk → improve retention
The counter-intuitive read
The app's lack of features is its primary risk: in the medical category…
Read the full takeSince the last report: The competitive outlook shifted from stable to declining, reflecting the increased risk of obsolescence as the app remains in a zombie state while the broader market adopts automated data synchronization.
Bottom line
Diabetes Tracker - myGlucose remains a static manual-entry tool in a market that has moved toward automated synchronization. Integrating Apple Health would unlock the utility required to remain relevant against modern, automated glucose-tracking alternatives.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated